These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29908921)

  • 1. IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling.
    Vahedi F; Lee AJ; Collins SE; Chew MV; Lusty E; Chen B; Dubey A; Richards CD; Feld JJ; Russell RS; Mossman KL; Ashkar AA
    Cytokine; 2019 Dec; 124():154439. PubMed ID: 29908921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.
    Zhao LJ; Wang W; Wang WB; Ren H; Qi ZT
    Cytokine; 2015 Mar; 72(1):17-24. PubMed ID: 25544181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
    Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
    Zhang S; Saha B; Kodys K; Szabo G
    J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
    Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
    PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.
    Serti E; Werner JM; Chattergoon M; Cox AL; Lohmann V; Rehermann B
    Gastroenterology; 2014 Jul; 147(1):209-220.e3. PubMed ID: 24685721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
    Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
    Kondadasula SV; Roda JM; Parihar R; Yu J; Lehman A; Caligiuri MA; Tridandapani S; Burry RW; Carson WE
    Blood; 2008 Apr; 111(8):4173-83. PubMed ID: 18174382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
    Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H
    J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV infection selectively impairs type I but not type III IFN signaling.
    Chandra PK; Bao L; Song K; Aboulnasr FM; Baker DP; Shores N; Wimley WC; Liu S; Hagedorn CH; Fuchs SY; Wu T; Balart LA; Dash S
    Am J Pathol; 2014 Jan; 184(1):214-29. PubMed ID: 24215913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.